NDC properties for NDC 9 55513-481
NDC item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen, Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Nuvaila Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
NDC item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| Labeler | Nuvaila Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |